You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 110 No. 6, December 1974 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (49)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Epidermolysis Bullosa Dystrophica With Epidermal Neoplasms

William B. Reed, MD; Joseph College, Jr., MD; Martin J. O. Francis, PhD; Hugh Zachariae, MD; Frederic Mohs, MD; Mary Ann Sher, BM, BCH; Ian B. Sneddon, MD, FRCP

Arch Dermatol. 1974;110(6):894-902.


Abstract

Patients with epidermolysis bullosa dystrophica (EBD) tend to develop epidermal neoplasms, usually low-grade squamous cell carcinoma of the skin and less commonly that of the mouth. There have been 21 reported cases in the literature, and we are adding seven new cases and providing a further history in a previously reported case.

The average EBD patient develops carcinomas after 30 years of age, and some of these patients live to be 60 years of age before they die from the carcinoma. More than two thirds of the patients die from metastases.

In our patients, carcinoma developed in the mouth, ostium cardiacum, and in the midesophagus, with extension into the lungs. The cause remains unknown, but abnormal collagen scarring is the most likely cause. Carcinoma can probably develop in all the severe dystrophic types of EBD.



Author Affiliations

From the University of California, Irvine (Dr. Reed) and San Diego (Dr. College); the Nuffield Orthopedic Hospital, Oxford, England (Dr. Francis); the University of Aarhus Medical School, Aarhus, Denmark (Dr. Zachariae); the University of Wisconsin Medical School, Madison (Dr. Mohs); University of Johannesburg Medical School, South Africa (Dr. Sher); Rupert Hallam Hospital, Department of Dermatology, Sheffield, England (Dr. Sneddon).


Footnotes

Accepted for publication May 21, 1974.

Reprint requests to 1013 W Olive Ave, Burbank, CA 91505 (Dr. Reed).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Generalized Atrophic Benign Epidermolysis Bullosa in 2 Siblings Complicated by Multiple Squamous Cell Carcinomas
Swensson and Christophers
Arch Dermatol 1998;134:199-203.
ABSTRACT | FULL TEXT  

Malignant Melanoma and a Squamous Cell Carcinoma in Recessive Dystrophic Epidermolysis Bullosa
Chorny et al.
Arch Dermatol 1993;129:1212-1212.
ABSTRACT  

Recessive Dystrophic Epidermolysis Bullosa Skin Displays a Chronic Growth-Activated Immunophenotype: Implications for Carcinogenesis
Smoller et al.
Arch Dermatol 1990;126:78-83.
ABSTRACT  

Natural Killer Cell Activity Is Reduced in Patients With Severe Forms of Inherited Epidermolysis Bullosa
Tyring et al.
Arch Dermatol 1989;125:797-800.
ABSTRACT  

Tissue Stress and Tumor Promotion: Possible Relevance to Epidermolysis Bullosa
Goldberg et al.
Arch Dermatol 1988;124:737-741.
ABSTRACT  

Blastomycosis-like Pyoderma
Su et al.
Arch Dermatol 1979;115:170-173.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1974 American Medical Association. All Rights Reserved.